文献速递血栓与止血

静脉血栓栓塞症风险预测的基因组科学:便捷的澄清还是叠加的复杂性

Genomic science of risk prediction for venous thromboembolic disease: convenient clarification or compounding complexity.
PubMed 文献 · J Thromb Haemost · 2023-10-12

静脉血栓栓塞症(VTE)每年每1000人中发生1至2例,抗凝治疗可预防VTE但增加出血风险,因此需识别高危个体并给予预防性干预。本文综述VTE遗传风险因素及遗传预测模型,探讨将遗传发现加入临床预测模型能否改善风险预测及其临床意义与挑战,但模型是否最终具有临床效用仍待证实。

要点

  • VTE每年每1000人中发生1至2例,抗凝治疗可预防VTE但增加出血风险。
  • 将遗传发现加入临床预测模型可能改善VTE风险预测,尤其对高危个体。
  • 遗传预测模型是否最终具有临床效用仍待证实。

核心结论

  • 将遗传发现加入临床预测模型可改善VTE风险预测,尤其对高危个体可能带来更好的VTE预防和减少不必要治疗所致出血副作用,但模型是否最终具有临床效用仍待证实。

研究设计与样本

  • 综述,回顾VTE遗传风险因素的现有知识、遗传预测模型及其临床意义与挑战。

主要发现

  • VTE指静脉中异常血凝块,每年每1000人中发生1至2例。
  • 抗凝治疗可预防VTE但增加出血风险,凸显识别高危个体并给予预防性干预以减少VTE和出血风险的重要性。
  • 当前VTE风险评估主要基于临床风险因素的组合。
  • 随着越来越多与VTE风险相关的遗传变异被发现,将遗传发现加入临床预测模型可改善VTE风险预测。
  • 对高危个体,遗传发现加入临床预测模型的附加价值可能带来更好的VTE预防和减少不必要治疗所致出血副作用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 这些模型是否最终具有临床效用仍待证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Venous thromboembolism (VTE) refers to abnormal blood clots in veins occurring in 1 to 2 per 1000 individuals every year. While anticoagulant treatment can prevent VTE, it increases the risk of bleeding. This emphasizes the importance of identifying individuals with a high risk of VTE and providing prophylactic interventions to these individuals to reduce both VTE and bleeding risks. Current risk assessment of VTE is based on the combination of mainly clinical risk factors. With the identification of an increasing number of genetic variants associated with the risk of VTE, the addition of genetic findings to clinical prediction models can improve risk prediction for VTE. Especially for individuals in high-risk situations, the added value of genetic findings to clinical prediction models may have benefits such as better prophylaxis of VTE and the reduced side effects of bleeding from unnecessary treatment. Nevertheless, the question of whether these models will eventually have clinical utility remains to be proven. Here, we review the current state of knowledge on genetic risk factors for VTE, explore genetic prediction models for VTE, and discuss their clinical implications and challenges.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Han J, van Hylckama Vlieg A, Rosendaal FR, et al. Genomic science of risk prediction for venous thromboembolic disease: convenient clarification or compounding complexity. J Thromb Haemost. 2023. PMID: 37838557. doi:10.1016/j.jtha.2023.09.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。